Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
-
Market Cap
37.09B
Enterprise Value
44.39B
Income
1.69B
Sales
15.53B
Book/sh
5.29
Cash/sh
0.54
Employees
22000
IPO
May 04, 2023
P/E
21.97
Forward P/E
15.53
PEG
2.15
P/S
2.39
P/B
3.65
P/C
35.70
P/FCF
15.86
EV/EBITDA
12.40
EV/Sales
2.86
Quick Ratio
0.66
Current Ratio
0.96
Debt/Eq
0.82
LT Debt/Eq
0.71
Option/Short
Yes / No
EPS (ttm)
0.88
EPS next Y
1.24
EPS next Q
0.26
EPS this Y
8.37%
EPS next Y
6.26%
EPS next 5Y
7.21%
EPS past 3/5Y
-10.84% -
Sales past 3/5Y
0.43% 0.89%
EPS Y/Y TTM
16.81%
Sales Y/Y TTM
3.50%
EPS Q/Q
7.87%
Sales Q/Q
3.27%
Insider Own
0.25%
Insider Trans
-0.87%
Inst Own
94.51%
Inst Trans
0.95%
ROA
6.27%
ROE
16.25%
ROIC
9.75%
Gross Margin
58.62%
Oper. Margin
19.42%
Profit Margin
10.88%
SMA20
3.57%
SMA50
4.91%
SMA200
6.15%
Trades
Shs Outstand
1.92B
Shs Float
1.92B
52W High
20.13 -4.07%
52W Low
14.06 37.34%
Volatility
1.89% 1.76%
ATR (14)
0.38
RSI (14)
59.98
Beta
0.40
Rel Volume
0.00
Avg Volume
22.71M
Volume
0
Perf Week
-0.10%
Perf Month
9.78%
Perf Quarter
0.68%
Perf Half Y
9.22%
Perf YTD
11.94%
Perf Year
35.60%
Perf 3Y
3.59%
Perf 5Y
-
Perf 10Y
-
Prev Close
19.31
Price
19.31
Change %
0.00%
Consensus
Hold
Avg. Price Target
$19.67
Implied Upside
+1.9%
Analysts15incl. previous ratings
Rating Distribution3 Buy · 11 Hold · 1 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jan 30, 2026Downgrade
JEF logoJJefferies
Buy → Hold$18-6.8%
Oct 29, 2025Downgrade
CCanaccord Genuity
Buy → Hold$15-22.3%
Sep 26, 2025Upgrade
RRothschild & Co Redburn
Neutral → Buy$22+13.9%
Apr 10, 2025Initiated
RRedburn Atlantic
Neutral$23.50+21.7%
Mar 24, 2025Initiated
EVR logoEEvercore ISI
In-line$25+29.5%
Jan 06, 2025Upgrade
PPiper Sandler
Neutral → Overweight$21 → $26+34.6%
Dec 12, 2024Downgrade
DB logoDDeutsche Bank
Buy → Hold$25 → $24+24.3%
Sep 24, 2024Initiated
JEF logoJJefferies
Buy$27+39.8%
Sep 24, 2024Downgrade
RY logoRRBC Capital Mkts
Outperform → Sector Perform$24+24.3%
May 28, 2024Resumed
C logoCCitigroup
Neutral$21+8.8%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dasgupta AnindyaGroup President APACJul 31 '26Option Exercise0.0016,419016,419Aug 04 04:30 PM
Howlett HeatherCFO & CAOJun 10 '26Sale18.113,70066,98829,288Jun 12 04:11 PM
Howlett HeatherOfficerJun 10 '26Proposed Sale18.113,70066,988Jun 10 01:24 PM
Curado Gomes de Lemos LeonardoGroup President LATAMMay 01 '26Option Exercise0.0024,248024,248May 26 05:10 PM
Orlando MatthewGeneral CounselMay 08 '26Sale17.6638,491679,6910May 12 04:27 PM
Orlando MatthewOfficerMay 08 '26Proposed Sale17.6638,492679,691May 08 04:12 PM
Stevens MeredithChief Operations OfficerMar 10 '26Option Exercise0.005,170094,877Mar 12 07:14 PM
Alvarado LuaniChief People OfficerMar 10 '26Option Exercise0.004,222062,797Mar 12 07:14 PM
Lawson CarltonGroup President EMEA & LAMar 10 '26Option Exercise0.006,1580111,415Mar 12 07:14 PM
Lawson CarltonGroup President EMEA & LAMar 05 '26Option Exercise0.007,7360105,257Mar 09 05:03 PM
Alvarado LuaniChief People OfficerMar 05 '26Option Exercise0.004,289061,365Mar 09 05:03 PM
Stevens MeredithChief Operations OfficerMar 05 '26Option Exercise0.006,178092,224Mar 09 05:02 PM
Howlett HeatherVP & Chief Accounting OfficerMar 05 '26Option Exercise0.002,723033,921Mar 09 05:02 PM
Howlett HeatherVP & Chief Accounting OfficerMar 03 '26Option Exercise0.001,534031,724Mar 04 05:14 PM
Stevens MeredithChief Operations OfficerFeb 13 '26Option Exercise0.0028,040090,862Feb 18 08:35 PM
Alvarado LuaniChief People OfficerFeb 13 '26Option Exercise0.0015,942060,722Feb 18 08:35 PM
Lawson CarltonGroup President EMEA & LAFeb 13 '26Option Exercise16.5239,426651,36597,521Feb 18 08:35 PM
Howlett HeatherVP & Chief Accounting OfficerFeb 13 '26Option Exercise0.0013,571033,284Feb 18 08:35 PM
Alvarado LuaniChief People OfficerFeb 06 '26Option Exercise13.7685,5341,176,948118,183Feb 10 04:19 PM
Dyer RussellChief Corp. Affairs OfficerDec 15 '25Option Exercise0.004,90805,204Dec 17 05:48 PM
Perry KirkChief Executive OfficerDec 15 '25Option Exercise0.00118,5620118,562Dec 17 05:48 PM
Tillett CarolineChief Scientific OfficerDec 15 '25Option Exercise0.0033,923068,038Dec 17 05:48 PM
Orlando MatthewGeneral CounselDec 15 '25Option Exercise0.0023,921041,520Dec 17 05:48 PM
Smith Jeffrey CDirectorDec 12 '25Buy17.373,200,00055,593,60027,307,632Dec 15 04:00 PM
Smith Jeffrey CDirectorDec 11 '25Buy17.433,177,69455,392,92624,107,632Dec 15 04:00 PM
Orlando MatthewGeneral CounselDec 01 '25Option Exercise0.004,378030,870Dec 03 05:06 PM
Lawson CarltonGroup President EMEA & LADec 01 '25Option Exercise0.001,779058,095Dec 03 05:06 PM
Stevens MeredithChief Operations OfficerDec 01 '25Option Exercise0.002,776067,217Dec 03 05:06 PM
Alvarado LuaniChief People OfficerDec 01 '25Option Exercise0.002,021033,380Dec 03 05:06 PM
Tillett CarolineChief Scientific OfficerDec 01 '25Option Exercise0.001,539045,668Dec 03 05:06 PM
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson's, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.
CEO & DirectorMr. Kirk L. Perry
Chief Technology & Data OfficerMr. Michael P. Wondrasch
General CounselMr. Matthew Orlando
Group President of EuropeMr. Carlton Lawson
Interim CFO & Chief Accounting OfficerMs. Heather R. Howlett